We are excited to be attending the #PepTalk Virtual Conference: 19th-21st January. What an excellent opportunity to bring together the protein science community. We have broad and deep expertise in antibody and complex peptide therapeutics so please get in touch at bd@irbm.com to organise…
IRBM's Michele Luche, Heidi Kingdon Jones and Sven Zimmer will all be attending Fierce JPM Week. Please get in touch on the Brella portal if you would like to arrange a meeting with one of the team and learn how we can support your drug…
At IRBM we have a passion to help companies with their discovery and optimization challenges of small molecule drug candidates. One of our favourite events to meet people and discuss this fascinating topic is drugdiscoverychemisty which is online from 25-28…
Manuel Daldin, Scientist - High Throughput Biology and Screening and Heidi Kingdon Jones, Global VP Business Development are attending the Biomarker conference in Manchester. Manuel will be presenting on the “development and validation of an assay to detect mutant huntingtin…
Next week, IRBM’s Vice Presidents, Dan Conlon and Michele Luche will be attending the annual JP Morgan Healthcare Conference – the largest healthcare investment symposium in the industry. Get in touch to organise a meeting with Dan and Michele to…
Our Global VP of Sales and Marketing, Heidi Kingdon Jones, is attending TIDES Europe: Oligonucleotide and Peptide Therapeutics in Amsterdam. Running from November 12-15, the event is Europe's primary forum for thought leaders in this growing field to network and…
From November 11-13, we will be attending BIO-Europe in Hamburg. Our Global VP of Sales and Marketing, Heidi Kingdon Jones, and VP of North American Business Development, Michele Luche, will be on hand to talk about our exceptional drug discovery…